Recent advances in cancer treatment have brought new waves of immunotherapy and targeted therapy. Key immunotherapy approaches include immune checkpoint inhibitors, CAR-T cell therapy and cancer vaccines, which are revolutionising treatment options and improving patient outcomes.
Meanwhile, by targeting specific pathways essential for cancer growth, targeted therapies minimise damage to healthy cells, leading to more effective and less toxic treatments. Precision medicine techniques, such as genomic profiling, help identify suitable targets for these therapies, enabling personalised treatment strategies tailored to individual patients.

These innovative approaches represent significant advances in the fight against cancer, offering hope for improved survival rates and better quality of life. As research continues to unravel the complexities of cancer biology, the future of immunotherapy and targeted therapy holds great promise for changing the landscape of cancer care.

ISCRIZIONI

Per iscriversi è necessario accedere alla piattaforma DEEP e seguire le istruzioni che seguono:

IMPORTANTE! Se si accede alla piattaforma DEEP per la prima volta, è necessario cliccare su CREA ACCOUNT e registrare l'indirizzo e-mail e una password personale, che servirà poi in fase di login.

Successivamente, effettuare il LOGIN con le credenziali personali scelte in fase di creazione account: e-mail, password il seguente PIN -->  MED2024

All’interno del corso cliccare sul tasto ISCRIZIONE per completare i passaggi e finalizzare l'iscrizione. 

ACCEDI A DEEP PER L'ISCRIZIONE: https://ecm.deepapp.it/UsersLogin.aspx

Per informazioni , contattare: Manuela Ciufo mob: 338 5089489